Philip M. Hanno MD, MPH
Clinical Professor of Urology, Stanford University School of Medicine, Stanford, California
Dr. Philip Hanno specializes in the treatment of urologic chronic pain syndromes including bladder pain syndrome/interstitial cystitis and chronic pelvic pain syndrome in men (nonbacterial prostatitis). He sees patients with voiding dysfunction, urinary tract infection, and general urologic problems as well. From 1981 to 1990 he was an Associate Professor of Urology at the Hospital of the University of Pennsylvania and Chief of Urology at the Philadelphia Veterans Administration Medical Center. For the next decade he was Chairman of Urology at Temple University School of Medicine. After a year as a medical officer in the Food and Drug Administration in Washington, he returned to the University of Pennsylvania in 1999 as Professor of Urology. He came to Stanford in October 2016.
He has studied bladder pain syndrome both from a basic science and clinical perspective for much of his career and has published extensively on the syndrome. He is co-chair of the Medical Advisory Board of the Interstitial Cystitis Association and on the executive board of the International Society for the Study of Bladder Pain Syndrome (ESSIC). He is past Chair of the Bladder Pain Syndrome Guideline Committee of the American Urological Association.
Dr. Hanno focuses on the non-operative management of common urologic conditions with his special interest being helping patients with urologic chronic pain syndromes.
He has studied bladder pain syndrome both from a basic science and clinical perspective for much of his career and has published extensively on the syndrome. He is co-chair of the Medical Advisory Board of the Interstitial Cystitis Association and on the executive board of the International Society for the Study of Bladder Pain Syndrome (ESSIC). He is past Chair of the Bladder Pain Syndrome Guideline Committee of the American Urological Association.
Dr. Hanno focuses on the non-operative management of common urologic conditions with his special interest being helping patients with urologic chronic pain syndromes.
Disclosures
Philip Hanno MD, MPH acts as a consultant to Seikagaku, Imbrium, and Shionogi.
Recent Contributions to PracticeUpdate:
- Hyperbaric Oxygen in Urological Diseases
- AUA 2019: Dr. Philip Hanno's Session Recommendations for Infectious and Inflammatory Conditions
- 2018 Top Stories in Urology: Severe Maculopathy Linked With Use of Sodium Pentosan Polysulfate
- Urologic and Nonurologic Presentation in Bladder Pain Syndrome With and Without Hunner Lesions
- 5-Day Nitrofurantoin Superior to Single-Dose Fosfomycin for Clinical Resolution of Uncomplicated Lower UTI in Women
- AUA 2018: Dr. Philip Hanno's Session Recommendations for Infectious and Inflammatory Conditions
- Efficacy and Safety of Bladder Body vs Trigonal Intravesical OnabotulinumtoxinA Injection in the Treatment of Interstitial Cystitis Refractory to Conventional Treatment
- Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Bladder Pain Syndrome/Interstitial Cystitis Patients
- 2017 Top Stories in Urology: Bladder Pain Syndrome
- Can Cranberries Contribute to Reduce the Incidence of Urinary Tract Infections?